Foley Partner Louis Lehot Quoted in Crunchbase Discussing SPACs Searching for Targets
March 2, 2022
Crunchbase News
Foley & Lardner LLP Partner Louis Lehot was quoted in a Crunchbase News article titled, “The Market Minute: The Clock Is Ticking For SPACs – Here’s What Happens When They Can’t Seal A Deal,” discussing the stacked pipeline of SPACs searching for targets and a challenging macroeconomic environment that has largely stalled new public stock offerings.
Lehot commented, “SPACs will have to hustle harder than ever to get deals done. Otherwise, they have to look at their options. SPACs that are approaching their deadlines have roughly four options.”
People
Related News
October 9, 2026
In the News
Jonathan Lasken Highlighted Across the Media for Arrival to Foley
Foley & Lardner LLP partner Jonathan Lasken is highlighted across the media for his recent arrival to the firm’s Washington D.C. office.
October 7, 2026
In the News
William Holtz Examines New FDA Approach to Clinical Trial Development
Foley & Lardner LLP of counsel William Holtz is quoted in the PharmaVoice article, “5 Key Facts About the FDA Expedited IND Pilot Program,” examining the FDA's new pilot program and its potential to accelerate clinical research.
October 5, 2026
In the News
Louis Lehot Analyzes U.S. IPO Market Trends and Outlook
Foley & Lardner LLP partner Louis Lehot is featured in the Daily Journal‘s Capital & Counsel newsletter offering insights on the current state of the U.S. IPO market and the factors influencing companies' routes to going public.